Access Alert: Medical products regulatory harmonisation – increasing life-saving access for all

Access Alert: Medical products regulatory harmonisation – increasing life-saving access for all

Increasing regulatory harmonisation drives efficiencies by conserving public resources, attracting investment, and combating corruption. Furthermore, harmonisation efforts in the medical products sector play a vital role in ensuring public safety and enhancing access to life-saving products for all.

Since its establishment in 2009, the Asia-Pacific Economic Cooperation (APEC) Regulatory Harmonization Steering Committee (RHSC) has convened a tripartite network of regulators, industry stakeholders, and academia to accelerate regulatory convergence and reliance within the APEC region.

Access Partnership team members have long served as advisors to the RHSC Co-Chairs and helped to design and launch the RHSC’s Centers of Excellence for Regulatory Science (CoEs). Leveraging a curriculum that promotes internationally recognised guidelines and best practices, the 20+ CoEs have trained thousands of regulators and industry professionals.

During the first APEC Senior Officials’ Meeting of 2024 in Lima, Peru, Access Partnership’s Senior Vice President Patricia Wu and Consultant Anne Blatchford in their capacity as Advisors to the RHSC Co-Chairs worked with the Co-Chairs, the U.S. Food & Drug Administration and the Pharmaceuticals and Medical Devices Agency of Japan, their trade and foreign ministry counterparts, and other delegations to endorse the terms of reference for the work to continue.

As a result of these efforts, and recognising that regulatory harmonisation is an ongoing journey, the RHSC looks forward to building on past successes and incubating new ideas in 2024. This includes working to drive the adoption of internationally recognised standards from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and the International Medical Device Regulatory Forum. More information on these goals can be found in a joint update issued by the US Department of State, Department of Health and Human Services, and Office of the United States Trade Representative.

The RHSC will also seek to expand training services for thousands of regulators and industry members through the CoEs, as well as cultivate political will for convergence and reliance among regulatory policymakers.

To discover how organisations can leverage the regulatory convergence efforts spearheaded by the RHSC and supported by Access Partnership, please contact Patricia Wu at [email protected] and Anne Blatchford at [email protected].

Related Articles

AI for All in Thailand: Building an AI-ready economy with Google

AI for All in Thailand: Building an AI-ready economy with Google

อ่านบทความนี้เป็นภาษาไทย A doctor in Bangkok analyzes medical images with AI, leading to a faster, more accurate diagnosis for her patient....

19 Dec 2024 AI Policy Lab
The Role of Earth Observation in Combating Desertification in Middle Eastern Countries

The Role of Earth Observation in Combating Desertification in Middle Eastern Countries

This month’s UNCCD COP16 in Riyadh marked a pivotal moment in combating global land degradation and drought, with outcomes including...

13 Dec 2024 Opinion
Access Alert: Enhancing Efficiency in India’s Logistics Through AI and Digital Integration

Access Alert: Enhancing Efficiency in India’s Logistics Through AI and Digital Integration

A recent panel discussion at the Bengaluru Tech Summit 2024 on 20 November 2024 focused on the transformative role of...

29 Nov 2024 Opinion
Access Alert: How Will Deepfake Regulations in APAC Impact Your Business?

Access Alert: How Will Deepfake Regulations in APAC Impact Your Business?

The rise of deepfakes – AI-generated content that manipulates audio, video, or images to create realistic but false representations –...

29 Nov 2024 Opinion